May 26, 2021 / NTS GMT
Presentation
May 26, 2021 / NTS GMT
=====================
Corporate Participants
=====================
* Bernhardt G. Zeiher
Astellas Pharma Inc. - Chief Medical Officer & President of Development
* Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Representative Director
* Naoki Okamura
Astellas Pharma Inc. - Corporate Executive VP, CFO, Chief Strategy Officer & Representative Director
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
* Tatsuyuki Arai
BofA Securities, Research Division - Junior Analyst
=====================
Astellas Pharma Inc
(STU:YPH)
€
11.3
-0.10 (-0.88%)
Market Cap: 20.83 Bil
Enterprise Value: 22.33 Bil
PE Ratio: 13.32
PB Ratio: 2.12
GF Score: 84/100 Astellas Pharma Inc. Corporate Strategic Plan Presentation Transcript
May 26, 2021 / NTS GMT
Release Date Price:
€12.56
(+1.33%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot